| S.No. |
Products |
Packing |
Composition |
| 1 |
|
|
| Clarithromycin I.P. 1% w/w |
|
| 2 |
|
|
| Clarithromycin USP 1% w/v |
|
| 3 |
|
|
| Clindamycin Phosphate USP eq. to Clindamycin 1% w/w |
|
| 4 |
|
|
| Clindamycin Phosphate USP eq. to Clindamycin 1% w/v |
|
| 5 |
|
|
| Fluconazole 50 mg Dispersible Tablets |
|
| 6 |
|
|
| Fluconazole 150 mg Dispersible Tablets |
|
| 7 |
|
|
| Fluconazole 400 mg Tablets |
|
| 8 |
|
|
| Ketoconazole 2% w/v + ZPTO 1% w/v Lotion |
|
| 9 |
|
|
| Beclomethasone Dipropionate I.P. 0.025% w/w + Clotrimazole I.P. 1% w/w + Neomycin Sulphate I.P. 0.5% w/w in Cream Base |
|
| 10 |
|
|
|
| 11 |
|
|
|
| 12 |
|
|
| Isotretinoin USP 10 mg Capsules |
|
| 13 |
|
|
| Isotretinoin USP 20 mg Capsules |
|
| 14 |
|
|
| Levocetirizine Dihydrochloride 5 mg Tablets |
|
| 15 |
|
|
| Levocetirizine Dihydrochloride 10 mg Tablets |
|
| 16 |
|
|
| Montelukast Sodium 10 mg + Levocetirizine Dihydrochloride 5 mg Tablets |
|
| 17 |
|
|
| Salicylic Acid 2.0% w/w, Cetyl Alcohol 2.65% w/w, Stearyl Alcohol 0.26% w/w |
|
| 18 |
|
|
| Mometasone Furoate 0.1% w/w + Salicylic Acid 5% w/w Ointment |
|
| 19 |
|
|
| Cetirizine hydrochloride 10 mg Tablets |
|
| 20 |
|
|
| Cetirizine hydrochloride 5 mg Tablets |
|
| 21 |
|
|
| Cetirizine hydrochloride 20 mg Tablets |
|
| 22 |
|
|
| Terbinafine Hydrochloride equivalent to Terbinafine 250 mg Tablets |
|
| 23 |
|
|
| Terbinafine Hydrochloride 1% w/w |
|
| 24 |
|
|
| Clobetasol Propionate BP 0.05% w/w |
|
| 25 |
|
|
| Clobetasol Propionate BP 0.05 % w/w |
|
| 26 |
|
|
| Clobetasol Propionate BP 0.05% w/w |
|
| 27 |
|
|
| Clobetasol Propionate BP 0.05% w/w+ Salicylic Acid IP 6.00% w/w |
|
| 28 |
|
|
| Clobetasol Propionate BP 0.05% w/v+ Salicylic Acid IP 3.00% w/v |
|
| 29 |
|
|
| Clobetasol Propionate BP 0.05% w/w, Salicylic Acid IP 3.00% w/w |
|
Cardiology & Diabetology